Records containing: Lymphatic Malformation
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Lymphatic Anomalies Registry for the Assessment of Outcome Data
-
CLINICAL_TRIALS study record update · 2026-03-05Weekly Sirolimus Therapy for the Treatment of Venous and Lymphatic Malformations
-
CLINICAL_TRIALS study record update · 2026-02-23Evaluation Nationale Des Enfants et Adultes Avec Syndromes d'Hypercroissance Dysharmonieuse National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
-
CLINICAL_TRIALS study record update · 2026-02-19A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)
-
CLINICAL_TRIALS study record update · 2026-02-18A Prospective Randomized Controlled Study on the Treatment of Cystic Lymphatic Malformation Based on Indocyanine Green-fluorescence Imaging
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-130.1% Topical Sirolimus in the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children and Adults: Phase II, Split-body Randomized, Double-blind, Vehicle-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-12-16Evaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor Prognosis
-
CLINICAL_TRIALS study record update · 2025-10-23A Phase 2a/b Single Arm Open Label Study to Evaluate the Safety and Efficacy of Intracystic Administration of TARA-002 in Participants Between 6 Months to Less Than 18 Years of Age for the Treatment of Macrocystic and Mixed Cystic Lymphatic Malformations
-
CLINICAL_TRIALS study record update · 2025-06-22Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) as Diagnostic Imaging for Lymphatic, Venous and Arteriovenous Malformations
-
CLINICAL_TRIALS study record update · 2025-03-25Prospective and Retrospective Clinical Study of Lymphatic Malformations: Institution of an Italian REGistry of Lymphatic Malformations and of a Biobank for Biological Sample Collection
-
CLINICAL_TRIALS study record update · 2025-03-13Application Value of Indocyanine Green Lymphography in Management of Microcystic Lymphatic Malformation of the Tongue
-
CLINICAL_TRIALS study record update · 2024-12-31Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
-
CLINICAL_TRIALS study record update · 2024-06-03Efficacy and Safety of Different Concentrations of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
-
CLINICAL_TRIALS study record update · 2024-02-14Clinical Characteristics of Lymphatic Malformations: An Observational Study
-
CLINICAL_TRIALS study record update · 2022-08-04Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
-
CLINICAL_TRIALS study record update · 2022-04-21Validation of Core Biopsy of Vascular Anomalies for Clinical Pathology and Genomics
-
CLINICAL_TRIALS study record update · 2022-03-22A Phase 1b, Open-Label, Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults (Aged 18-31 Years) With Complex Lymphatic Malformations